Elevated Serum Levels of Resistin, Leptin, and Adiponectin are Associated with C-reactive Protein and also Other Clinical Conditions in Rheumatoid Arthritis
スポンサーリンク
概要
- 論文の詳細を見る
Objective Body fat is an important source of hormones and cytokines (adipokines) that not only regulate the energy balance, but also regulate the inflammatory and immune responses. This study investigated the association of clinical conditions with serum levels of adipokines in patients with rheumatoid arthritis. Methods Serum levels of resistin, leptin, and adiponectin were measured by enzyme-linked immunosorbent assay in 141 patients (110 women) who fulfilled the 1987 revised criteria of the American Rheumatism Association for the diagnosis of rheumatoid arthritis and in 146 normal controls (124 women). Then the correlations between adipokine levels and clinical parameters were evaluated. Results The serum resistin level did not differ between the patients and controls. However, serum leptin levels were significantly higher in male and female rheumatoid arthritis patients than in the corresponding controls, while the serum adiponectin level was significantly higher in female patients than in female controls. Multivariate analysis revealed that predictors of an elevated resistin level were female sex and C-reactive protein (CRP), while the leptin level was related to the body mass index and CRP. Predictors of an elevated adiponectin level were the use of prednisolone and CRP, however, CRP was negatively associated with adiponectin in patients with rheumatoid arthritis. Conclusion The serum levels of resistin and leptin were positively associated with CRP level in patients with rheumatoid arthritis, suggesting that these adipokines may act as pro-inflammatory cytokines in this disease. The serum adiponectin level was elevated in the patients, however, it was negatively associated with CRP level. In addition, the serum levels of resistin, leptin, and adiponectin were also associated with female sex, BMI and the use of prednisolone, respectively.
著者
-
TANAKA Nahoko
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
KUSUNOKI Yoshie
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
KANEKO Kaichi
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
ENDO Hirahito
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
KAWAI Shinichi
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine
-
Yoshino Takumi
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicin
-
Kusunoki Natsuko
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicin
-
Hasunuma Tomoko
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicin
-
Endo Hirahito
Division Of Rheumatology Department Of Internal Medicine Toho University School Of Medicine
-
Yoshino Takumi
Division Of Rheumatology Department Of Internal Medicine (omori) Toho University School Of Medicine
-
Kaneko Kaichi
Division Of Rheumatology Department Of Internal Medicine Toho University School Of Medicine
-
Kusunoki Yoshie
Division Of Rheumatology Department Of Internal Medicine Toho University School Of Medicine
-
Hasunuma Tomoko
Division Of Rheumatology Immunology And Genetic Program Institute Of Medical Science St. Marianna Un
-
Kawai Shinichi
Division Of Rheumatology Department Of Internal Medicine (omori) School Of Medicine Faculty Of Medicine
-
Kusunoki Natsuko
Division Of Rheumatology Department Of Internal Medicine (omori) School Of Medicine Faculty Of Medicine
-
Tanaka Nahoko
Division Of Rheumatology Department Of Internal Medicine (omori) School Of Medicine Faculty Of Medicine
-
Kawai Shinichi
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicine, Japan
-
Tanaka Nahoko
Division of Rheumatology, Department of Internal Medicine (Omori), Toho University School of Medicine, Japan
関連論文
- Systemic lupus erythematosus complicated by recurrent pneumothorax : Case report and literature review
- Elevated Serum Levels of Resistin, Leptin, and Adiponectin are Associated with C-reactive Protein and also Other Clinical Conditions in Rheumatoid Arthritis
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab
- Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus
- A case of systemic sclerosis complicated by idiopathic portal hypertension : case report and literature review
- Efficacy and safety of tacrolimus for lupus nephritis : a placebo-controlled double-blind multicenter study
- Rheumatoid Arthritis and Apoptosis
- Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis
- Safety of long-term tacrolimus therapy for rheumatoid arthritis : an open-label, uncontrolled study in non-elderly patients
- Tacrolimus therapy for systemic lupus erythematosus without renal involvement : a preliminary retrospective study
- Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts
- Recent Advances in Nonsteroidal Anti-Inflammatory Drugs
- Serum adipokine profiles in Kawasaki disease
- Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs-a multicenter, double-blind, parallel-group trial
- Clinical features of 405 Japanese patients with systemic sclerosis
- Incidence and the Risk Factor of Malignancy in Japanese Patients with Systemic Sclerosis
- Assessing the Cardiovascular Risk Between Celecoxib and Nonselective Nonsteroidal Antiinflammatory Drugs in Patients With Rheumatoid Arthritis and Osteoarthritis:– A 3-Year Nationwide Comparative Observational Study in Japan (ACCEPT) –
- A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy
- Resistin is associated with the inflammation process in patients with systemic autoimmune diseases undergoing glucocorticoid therapy : comparison with leptin and adiponectin